CR0000011, ND50021, ND1.4
CRMi005-A
General
Cell Line |
|
hPSCreg name | CRMi005-A |
Cite as: | CRMi005-A (RRID:CVCL_1E77) |
Alternative name(s) |
CR0000011, ND50021, ND1.4
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | No similar lines found. |
Last update | 22nd May 2019 |
User feedback | |
Provider |
|
Generator | National Institutes of Health - Center for Regenerative Medicine (CRM) |
Owner | NIH - National Institute of Neurological Disorders and Stroke (NINDS) |
Distributors | |
Derivation country | United States |
External Databases |
|
Cellosaurus | CVCL_1E77 |
BioSamples | SAMEA5070572 |
Wikidata | Q54922719 |
General Information |
|
Projects | |
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: allowed
Commercial use: allowed
|
Donor Information
General Donor Information |
|
Sex | male |
Ethnicity | unknown |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Disease associated phenotypes | no phenotypes |
Other Genotyping (Donor) |
|
Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
BioSamples | SAMEA1661708 |
Ethics
Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
Was the consent voluntarily given? | Yes |
Has the donor been informed that participation will not directly influence their personal treatment? | No |
Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
If you do not hold the Donor Consent Form, do you know who does? | Yes |
Please provide the contact information | ATCC: https://www.atcc.org/ |
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised |
Does consent explicitly allow the derivation of pluripotent stem cells? | No |
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
How may genetic information associated with the cell line be accessed? | Open Access |
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | No |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | No |
Do you have obligations to third parties in regard to the use of the cell line? | No |
Is there an MTA available for the cell line? | Yes |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
Source cell line name |
CCD-1079sk (ATCC CRL-2097) Derived from same source line (potentially other lot and donor, see below):
|
Source cell type |
Fibroblast from foreskin.
Synonyms
|
Source cell origin | |
Source cell line vendor | ATCC |
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Episomal |
Is reprogramming vector detectable? |
Unknown |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Surface coating | Matrigel/Geltrex |
Feeder cells |
No |
Medium | TeSR™ E8™ |
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
Microbiology / Virus Screening |
|
Mycoplasma | Negative |
Certificate of Analysis |
|
Is there a certificate of analysis available? |
Yes
Passage:
35
|
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Unknown
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.